(Q39616040)

English

RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cells

scientific article published on 24 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cells (English)

1 reference

Europe PubMed Central

13 September 2017

1 reference

based on heuristic

inferred from title

RNA interference

1 reference

based on heuristic

inferred from title

author name string

Guilin Li

1

1 reference

Europe PubMed Central

13 September 2017

Renzhi Wang

2

1 reference

Europe PubMed Central

13 September 2017

Jun Gao

3

1 reference

Europe PubMed Central

13 September 2017

Kan Deng

4

1 reference

Europe PubMed Central

13 September 2017

Junji Wei

5

1 reference

Europe PubMed Central

13 September 2017

Yanping Wei

6

1 reference

Europe PubMed Central

13 September 2017

publication date

24 December 2010

1 reference

Europe PubMed Central

13 September 2017

Molecular and Cellular Biochemistry

1 reference

Europe PubMed Central

13 September 2017

350

1 reference

Europe PubMed Central

13 September 2017

1-2

1 reference

Europe PubMed Central

13 September 2017

193-200

1 reference

Europe PubMed Central

13 September 2017

https://scigraph.springernature.com/pub.10.1007/s11010-010-0698-9

0 references

Changing paradigms--an update on the multidisciplinary management of malignant glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

ASPP [corrected] and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

The ASPP family: deciding between life and death after DNA damage

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

The expression of iASPP in acute leukemias

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Potential applications of RNA interference technology in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Lentivirus-delivered stable gene silencing by RNAi in primary cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

A flow cytometry assay simultaneously detects independent apoptotic parameters

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Abnormal mRNA expression of ASPP members in leukemia cell lines.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

The p53 gene and its role in human brain tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

D-type cyclin-dependent kinase activity in mammalian cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0698-9

21 January 2018

RNAi and cancer: Implications and applications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21184255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/21184255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p21: structure and functions associated with cyclin-CDK binding.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21184255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21184255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/21184255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11010-010-0698-9

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39616040&oldid=1845460870"